Literature DB >> 29933925

Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe.

Florian Douam1, Alexander Ploss2.   

Abstract

Yellow fever (YF) was one of the most dangerous infectious diseases of the 18th and 19th centuries, resulting in mass casualties in Africa and the Americas. The etiologic agent is yellow fever virus (YFV), and its live-attenuated form, YFV-17D, remains one of the most potent vaccines ever developed. During the first half of the 20th century, vaccination combined with mosquito control eradicated YFV transmission in urban areas. However, the recent 2016-2018 outbreaks in areas with historically low or no YFV activity have raised serious concerns for an estimated 400-500 million unvaccinated people who now live in at-risk areas. Once a forgotten disease, we highlight here that YF still represents a very real threat to human health and economies. As many gaps remain in our understanding of how YFV interacts with the human host and causes disease, there is an urgent need to address these knowledge gaps and propel YFV research forward.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  flaviviruses; viral pathogenesis; yellow fever; yellow fever vaccine; yellow fever virus

Mesh:

Substances:

Year:  2018        PMID: 29933925      PMCID: PMC6340642          DOI: 10.1016/j.tim.2018.05.012

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  110 in total

1.  Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA.

Authors:  M Niedrig; M Lademann; P Emmerich; M Lafrenz
Journal:  Trop Med Int Health       Date:  1999-12       Impact factor: 2.622

2.  The transmission of yellow fever to Macacus rhesus. 1928.

Authors:  A Stokes; J H Bauer; N P Hudson
Journal:  Rev Med Virol       Date:  2001 May-Jun       Impact factor: 6.989

3.  Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles.

Authors:  Beate M Kümmerer; Charles M Rice
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

4.  Military medicine in the Spanish-American War.

Authors:  Alfred Jay Bollet
Journal:  Perspect Biol Med       Date:  2005       Impact factor: 1.416

5.  Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites.

Authors:  T J Chambers; A Grakoui; C M Rice
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

6.  The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner.

Authors:  Sven Miller; Stefan Kastner; Jacomine Krijnse-Locker; Sandra Bühler; Ralf Bartenschlager
Journal:  J Biol Chem       Date:  2007-02-02       Impact factor: 5.157

7.  Yellow fever in Africa and the Americas, 2016.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2017-08-11

8.  Mutagenesis of the yellow fever virus NS2B protein: effects on proteolytic processing, NS2B-NS3 complex formation, and viral replication.

Authors:  T J Chambers; A Nestorowicz; S M Amberg; C M Rice
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

9.  Yellow Fever Virus, but Not Zika Virus or Dengue Virus, Inhibits T-Cell Receptor-Mediated T-Cell Function by an RNA-Based Mechanism.

Authors:  James H McLinden; Nirjal Bhattarai; Jack T Stapleton; Qing Chang; Thomas M Kaufman; Suzanne L Cassel; Fayyaz S Sutterwala; Hillel Haim; Jon C Houtman; Jinhua Xiang
Journal:  J Infect Dis       Date:  2017-11-27       Impact factor: 5.226

10.  Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses.

Authors:  Denis Gaucher; René Therrien; Nadia Kettaf; Bastian R Angermann; Geneviève Boucher; Abdelali Filali-Mouhim; Janice M Moser; Riyaz S Mehta; Donald R Drake; Erika Castro; Rama Akondy; Aline Rinfret; Bader Yassine-Diab; Elias A Said; Younes Chouikh; Mark J Cameron; Robert Clum; David Kelvin; Roland Somogyi; Larry D Greller; Robert S Balderas; Peter Wilkinson; Giuseppe Pantaleo; Jim Tartaglia; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  J Exp Med       Date:  2008-12-01       Impact factor: 14.307

View more
  41 in total

Review 1.  Natural-Product-Based Solutions for Tropical Infectious Diseases.

Authors:  Oyelola Adegboye; Matt A Field; Andreas Kupz; Saparna Pai; Dileep Sharma; Michael J Smout; Phurpa Wangchuk; Yide Wong; Claire Loiseau
Journal:  Clin Microbiol Rev       Date:  2021-09-08       Impact factor: 50.129

2.  Role of Th17 Cytokines in the Liver's Immune Response during Fatal Yellow Fever: Triggering Cell Damage Mechanisms.

Authors:  Marcos Luiz Gaia Carvalho; Luiz Fábio Magno Falcão; Jeferson da Costa Lopes; Caio Cesar Henriques Mendes; Fábio Alves Olímpio; Vanessa do Socorro Cabral Miranda; Lais Carneiro Dos Santos; Daniel Dias Pinheiro de Moraes; Marcos Virgilio Bertonsin Filho; Luccas Delgado da Costa; Raimunda do Socorro da Silva Azevedo; Ana Cecília Ribeiro Cruz; Vanessa Costa Alves Galúcio; Lívia Caricio Martins; Maria Irma Seixas Duarte; Arnaldo Jorge Martins Filho; Jorge Rodrigues de Sousa; Pedro Fernando da Costa Vasconcelos; Juarez Antônio Simões Quaresma
Journal:  Cells       Date:  2022-06-28       Impact factor: 7.666

3.  Absence of yellow fever virus circulation in wildlife rodents from Brazil.

Authors:  Poliana de Oliveira Figueiredo; Ana Gabriella Stoffella-Dutra; Galileu Barbosa Costa; Jaqueline Silva de Oliveira; Carolina Dourado Amaral; Pedro Augusto Alves; José Dilermando Andrade Filho; Gustavo Fontes Paz; Gabriel Barbosa Tonelli; Erna Geessien Kroon; Betânia Paiva Drumond; Adriano Pereira Paglia; Danilo Bretas de Oliveira; Giliane de Souza Trindade
Journal:  Braz J Microbiol       Date:  2022-02-08       Impact factor: 2.214

Review 4.  Vaccination and Therapeutics: Responding to the Changing Epidemiology of Yellow Fever.

Authors:  Amanda Makha Bifani; Eugenia Z Ong; Ruklanthi de Alwis
Journal:  Curr Treat Options Infect Dis       Date:  2020-07-10

5.  Retinoic Acid Inducible Gene I and Protein Kinase R, but Not Stress Granules, Mediate the Proinflammatory Response to Yellow Fever Virus.

Authors:  Guillaume Beauclair; Felix Streicher; Maxime Chazal; Daniela Bruni; Sarah Lesage; Ségolène Gracias; Salomé Bourgeau; Laura Sinigaglia; Takashi Fujita; Eliane F Meurs; Frédéric Tangy; Nolwenn Jouvenet
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

6.  Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccination.

Authors:  Ismael Artur da Costa-Rocha; Ketty Lysie Libardi Lira Machado; Ana Carolina Campi-Azevedo; Andréa Teixeira-Carvalho; Vanessa Peruhype-Magalhães; Sheila Maria Barbosa de Lima; Emily Hime Miranda; Gisela Freitas Trindade; Thays Zanon Casagrande; Samira Tatiyama Miyamoto; Sávio Carvalho Deotti; Rafaela Villa Real Barbosa; Priscila Costa Martins Rocha; Erica Vieira Serrano; Valquiria Garcia Dinis; Sônia Alves Gouvêa; Maria Bernadete Renoldi de Oliveira Gavi; Lidia Balarini da Silva; Ruben Horst Duque; Ana Paula Espíndula Gianordoli; Maria de Fatima Bissoli; Maria da Penha Gomes Gouvea; Lauro Ferreira da Silva Pinto-Neto; Ana Paula Neves Burian; Francieli Fontana Sutile Tardetti Fantinato; Gecilmara Salviato Pileggi; Licia Maria Henrique da Mota; Valéria Valim; Olindo Assis Martins-Filho
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

7.  Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus.

Authors:  Michael P Doyle; Joseph R Genualdi; Adam L Bailey; Nurgun Kose; Christopher Gainza; Jessica Rodriguez; Kristen M Reeder; Christopher A Nelson; Prashant N Jethva; Rachel E Sutton; Robin G Bombardi; Michael L Gross; Justin G Julander; Daved H Fremont; Michael S Diamond; James E Crowe
Journal:  mBio       Date:  2022-04-14       Impact factor: 7.786

Review 8.  What Does the Future Hold for Yellow Fever Virus? (II).

Authors:  Raphaëlle Klitting; Carlo Fischer; Jan F Drexler; Ernest A Gould; David Roiz; Christophe Paupy; Xavier de Lamballerie
Journal:  Genes (Basel)       Date:  2018-08-21       Impact factor: 4.096

Review 9.  Modeling Arboviral Infection in Mice Lacking the Interferon Alpha/Beta Receptor.

Authors:  Alejandro Marín-Lopez; Eva Calvo-Pinilla; Sandra Moreno; Sergio Utrilla-Trigo; Aitor Nogales; Alejandro Brun; Erol Fikrig; Javier Ortego
Journal:  Viruses       Date:  2019-01-08       Impact factor: 5.048

10.  Midgut barriers prevent the replication and dissemination of the yellow fever vaccine in Aedes aegypti.

Authors:  Lucie Danet; Guillaume Beauclair; Michèle Berthet; Gonzalo Moratorio; Ségolène Gracias; Frédéric Tangy; Valérie Choumet; Nolwenn Jouvenet
Journal:  PLoS Negl Trop Dis       Date:  2019-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.